超越舒适区:强力运动作为预防良性前列腺增生症的预防策略
Wei Zhang1,2, Gang Li3, Chengya Hao4
1Capital University of Physical Education and Sports, Beijing, China.
American journal of men's health
|February 11, 2025
概括
剧烈的运动可以预防良性前列腺增生症 (BPH). 门德尔的随机化分析表明了因果关系,表明高强度运动可能是前列腺健康的预防策略.
科学领域:
- 遗传学 是一个遗传学.
- 流行病学 流行病学
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 剧烈的运动与前列腺扩大有关,但遗传因果关系尚不清楚.
- 良性前列腺增生 (BPH) 是一种常见的疾病,影响老年男性.
研究的目的:
- 通过使用孟德尔随机化来调查劳累性运动和BPH之间的潜在因果关系.
- 为了确定是否有遗传倾向致力于艰苦的运动影响BPH风险.
主要方法:
- 两个样本的孟德尔随机化 (MR) 分析.
- 利用单核酸多态 (SNPs) 用于艰苦的体育和BPH从全基因组关联研究 (GWAS).
- 采用逆变量加权 (IVW) 和加权中位数 (WM) 方法,并进行敏感性分析,包括MR-Egger和留出一个测试.
主要成果:
- 研究人员观察到,运动对BPH有显著的保护性因果作用 (IVW OR=0.927,p=0.020).
- 权重中位数方法证实了这些发现 (WM OR=0.904,p=0.011).
- 敏感性分析支持了结果的稳定性.
结论:
- 门德尔的随机化提供了可靠的因果证据,证明了与艰苦运动相关的BPH风险降低.
- 高强度运动可以作为保持前列腺健康的预防策略.
相关概念视频
Disorders of the Male Reproductive System
307
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
307
Exercise and Cardiovascular Response
706
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
706
Antihypertensive Drugs: Vasodilators
462
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
462
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
531
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
531
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
127
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
127
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
374
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
374


